This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Hypothermia Induced Impairment of Primary Haemostasis
and you are
between 18 and 50
years old
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

To study, with a prospective randomised controlled design, whether the subcutaneous administration of the haemostatic drug desmopressin, may improve the impairment of primary haemostasis due to mildly decreased temperature.

Provided treatments

  • Drug: desmopressin
  • Drug: desmopressin
  • Drug: desmopressin
  • Drug: placebo
Tris trial is registered with FDA with number: NCT00902057. The sponsor of the trial is The University of Hong Kong and it is looking for 48 volunteers for the current phase.
Official trial title:
Effect of Desmopressin on Platelet Dysfunction Associated With Mild Hypothermia in Healthy Volunteers